Richiedi una copia del documento: Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas. results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial

Captcha code
Annulla